Questions and Answers (5) View all
-
Answer added in Homology Modeling57 Can you recommend any homology modeling tools?By Priyanka Kshirsagar · Solapur UniversityDavid Watson · University of MississippiYou may also want to try out I-tasser for automated homology model development, depending upon your target.You may also want to try out I-tasser for automated homology model development, depending upon your target.Following
-
Answer added in Modeling and Docking3 What is molecular dynamics and simulation?By Prasanna Ranade · University of MumbaiDavid Watson · University of MississippiMolecular dynamics is an atomistic method of simulating the movement of molecules over (usually relatively short) time scales. It is predominantly use... [more]Molecular dynamics is an atomistic method of simulating the movement of molecules over (usually relatively short) time scales. It is predominantly used in the simulation of protein movements either with or without accompanying small molecules (ligands), cofactors, and allosteric modulators. One of the major goals of MD is to determine the stability or energetics of macromolecules as they interact with solvent and/or ligands. Over a sufficiently long enough time scale, a well designed simulation may provide insights into how molecules move, including information that can be extrapolated from the microscopic to the macroscopic level. Properties such as density, entropy, energy, and so on may be calculated by taking "snapshots" of the trajectory of the atoms in such a simulation.Following
-
Answer added in Modeling and Docking2 How to interpret Docking results?By Talal Awad · sudan academy of scienceDavid Watson · University of MississippiMy first question is whether or not you performed a validation with the native ligand, if applicable. Did it dock sufficiently close to the native cry... [more]My first question is whether or not you performed a validation with the native ligand, if applicable. Did it dock sufficiently close to the native crystal structure? Of course, if you are using a homology model, then there are whole host of other issues you need to worry about. Are there important waters in the vicinity of the ligand in the crystal structure? What about waters in homologous proteins or isoforms of your target? Rank ordering is but one of many ways of rationalizing the validity of a model. You might want to look at the similarity of the scaffolds that you are docking, and propose overall binding modes based upon that kind of analysis. You may also want to question whether or not there are highly-flexible side chains, which can be assessed from the B-factors in the original PDB file. Normal mode analysis may give you some insight into the characteristic motions of the protein in the vicinity of the orthosteric site. As for docking scores, they depend to an extent on the implementation of the software, and some targets are better treated with one type of scoring or software than others. Hydrogen bonding and electrostatics are a major driving force and may tend to overoptimistically place one compound in an unexpected binding mode ahead of others in the native state that have an abundance of "shape complementarity". These may be valid alternative binding modes and the interpretation is going to be up to you.Following
-
Answer added in Medicinal and Pharmaceutical Chemistry9 Can anyone suggest drugs regarding Triazoles and Oxadiazole available commercially?By Mohana Rao Katiki · Indian Institute of Chemical TechnologyDavid Watson · University of MississippiOne approach may be to search at drugbank.ca using a SMILES string. There may even be a way to limit the search to approved drugs.One approach may be to search at drugbank.ca using a SMILES string. There may even be a way to limit the search to approved drugs.Following
-
Answer added in QSAR4 reliable method for outlier detection and elimination in 3D QSAR CoMFA?By Nirzari Gupta · Nirma UniversityDavid Watson · University of MississippiIf you intend to reject outliers, there should be justifiable reason to do so, and rejections should be documented. Some outliers can provide valuable... [more]If you intend to reject outliers, there should be justifiable reason to do so, and rejections should be documented. Some outliers can provide valuable insights into alternative binding modes, activity cliffs, "magic methyl" groups, and so on. It would be unfortunate to overlook these data in order to build a model with desirable validation parameters.Following
Publications (2) View all
-
Article: Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects.
Rudolf Brenneisen, Mahmoud A Elsohly, Timothy P Murphy, Joseph Passarelli, Stefan Russmann, Salvatore J Salamone, David E Watson[show abstract] [hide abstract]
ABSTRACT: In Europe and the United States, the recreational use of gamma-hydroxy butyric acid (GHB) at dance clubs and "rave" parties has increased substantially. In addition, GHB is used to assist in the commission of sexual assaults. The aim of this controlled clinical study was to acquire pharmacokinetic profiles, detection times, and excretion rates in human subjects. Eight GHB-naïve volunteers were administered a single 25-mg/kg body weight oral dose of GHB, and plasma, urine, and oral fluid specimens were analyzed by using gas chromatography-mass spectrometry (GC-MS). Liquid-liquid extraction was performed after acid conversion of GHB to gamma-butyrolactone. Limits of quantitation of 0.1 (oral fluid), 0.2 (urine), and 0.5 microg/mL (plasma) could be achieved in the selected ion monitoring mode. GHB plasma peaks of 39.4 +/- 25.2 microg/mL (mean +/- SEM) occurred 20-45 min after administration. The terminal plasma elimination half-life was 30.4 +/- 2.45 min, the distribution volume 52.7 +/- 15.0 L, and the total clearance 1228 +/- 233 microL/min. In oral fluid, GHB could be detected up to 360 min, with peak concentrations of 203 +/- 92.4 microg/mL in the 10-min samples. In urine, 200 +/- 71.8 and 230 +/- 86.3 microg/mL, were the highest GHB levels measured at 30 and 60 min, respectively. Only 1.2 +/- 0.2% of the dose was excreted, resulting in a detection window of 720 min. Common side-effects were confusion, sleepiness, and dizziness; euphoria and change of vital functions were not observed. GHB is extensively metabolized and rapidly eliminated in urine and oral fluid. Consequently, samples should be collected as soon as possible after ingestion.Journal of analytical toxicology 28(8):625-30. · 2.02 Impact Factor -
Article: Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase.
[show abstract] [hide abstract]
ABSTRACT: We have previously cloned a cDNA encoding human prolylcarboxypeptidase (PRCP) and expressed the cDNA in the Schneider 2 (S2) drosophila cell line. Here, we further characterized this recombinant enzyme. Investigations were performed to determine whether recombinant PRCP (rPRCP) metabolizes kinins (BK 1-9 and BK 1-8). The metabolites of these kinins were identified by LC/MS. rPRCP metabolized BK 1-8 to BK 1-7, whereas rPRCP was ineffective in metabolizing BK 1-9. The hydrolysis of BK 1-8 by rPRCP was dose- and time-dependent. A homology model of PRCP was developed based upon the sequence of dipeptidyl-peptidase 7 (DPP7, PDB ID: 3JYH), and providentially, the structure of PRCP (PDB ID: 3N2Z) was characterized during the course of our investigation. Docking studies of bradykinin oligopeptides were performed both from the homology model, and from the crystal structure of PRCP. These docking studies may provide a better understanding of the contribution of specific residues involved in substrate selectivity of human PRCP.Biochemical and Biophysical Research Communications 02/2011; 405(3):338-43. · 2.48 Impact Factor